Request Deal Involvement

ZyVersa Therapeutics went public via a SPAC merger with Larkspur Health Acquisition in a $109m deal.

Identify your role

Select the side you represented in this transaction, and provide your current job title.

Service Providers

Noble Capital Markets

financial advisors

Noble Capital Markets

Lowenstein Sandler

legal advisors

Lowenstein Sandler

Benchmark Company

financial advisors

Benchmark Company

Alliance Global Partners

financial advisors

Alliance Global Partners

Manatt Phelps & Phillips

legal advisors to financial advisors

Manatt Phelps & Phillips

Alston & Bird

legal advisors

Alston & Bird

or

Principals

ZYVERSA THERAPEUTICS

target

ZYVERSA THERAPEUTICS

LARKSPUR HEALTH ACQUISITION CORP

bidder

LARKSPUR HEALTH ACQUISITION CORP

Principals or Service Provider not listed?Add missing Service Provider or Principal

Enter your Job Title on this deal

This title will appear on your profile next to this deal involvement.


To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:

All rights reserved. Copyright © 2025 Datasite